Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epi MA-T
- Development stage
- Unknown
- Lead developer
- EpiPharm
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Epi MA-T is a topical dermato-cosmetic cream developed by EpiPharm, a Swiss biotechnology company specializing in epigenetic skin health. The product is designed to address various skin disorders by leveraging EpiPharm's proprietary epigenetic platform, which aims to regulate gene expression patterns associated with skin pathology. Epi MA-T (also referred to by the code name AA-T) is part of a product line that includes Epi MA (for actinic keratosis) and Epi DA (for atopic dermatitis). While the specific molecular targets of Epi MA-T are not publicly detailed, the formulation is intended to restore healthy skin function through epigenetic modulation. It is currently classified as approved in certain contexts, bridging the gap between traditional cosmetics and pharmaceutical treatments for dermatological conditions.
- Brand names
- Epi MA-T
- Other names
- Epi MA-T cream
Beyond the preview
Go deeper on Epi MA-T.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epi MA-T.